AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(0.10) per share. This is a 16.67 percent increase over losses of $(0.12) per share from the same period last year.
Oppenheimer Maintains Outperform on BorgWarner, Raises Price Target to $57
Oppenheimer analyst Noah Kaye maintains BorgWarner (NYSE:BWA) with a Outperform and raises the price target from $50 to $57.
